| Antiviral | EC50 ratio | Phenotype | Strain | Source | Marker | Assay | Reference |
|---|---|---|---|---|---|---|---|
| Ganciclovir | 1.77 | No resistance | N/A | N/A | Recombinant | Details | Identification of resistance-associated HCMV UL97- and UL54-mutations and a UL97-polymporphism with impact on phenotypic drug-resistance. (Jul 2016) |
| Cidofovir | 0.47 | Possible hypersensitivity, no resistance | N/A | N/A | Recombinant | Details | Identification of resistance-associated HCMV UL97- and UL54-mutations and a UL97-polymporphism with impact on phenotypic drug-resistance. (Jul 2016) |
| Foscarnet | 2.50 | Low level resistance | N/A | N/A | Recombinant | Details | Identification of resistance-associated HCMV UL97- and UL54-mutations and a UL97-polymporphism with impact on phenotypic drug-resistance. (Jul 2016) |
| Mutant | Resistances |
|---|---|
| V715M |
Ganciclovir:
|
|
Cidofovir:
|
|
|
Foscarnet:
|